TableĀ 3 The prevalence of peripheral neuropathy among patients with type 2 diabetes mellitus in Jordan according to relevant socio-demographic, clinical and laboratory characteristics
Variables | Peripheral neuropathy | P value | |
|---|---|---|---|
Yes nā=ā396 | No nā=ā607 | ||
Gender | 0.137 | ||
Ā Male | 201 (41.9) | 279 (58.1) | Ā |
Ā Female | 195 (37.3) | 328 (62.7) | Ā |
Age (year) | <ā0.001 | ||
Ā <ā50 | 23 (17.4) | 109 (82.6) | Ā |
Ā 50ā69 | 269 (38.9) | 423 (61.1) | Ā |
Ā ā„ā70 | 104 (58.1) | 75 (41.9) | Ā |
Marital status | 0.777 | ||
Ā Single/divorced/widowed | 52 (40.6) | 76 (59.4) | Ā |
Ā Married | 344 (39.3) | 531 (60.7) | Ā |
Working status | <ā0.001 | ||
Ā Unemployed | 175 (50.9) | 169 (49.1) | Ā |
Ā Employed | 83 (29.6) | 197 (70.4) | Ā |
Ā Retired | 138 (36.4) | 241 (63.6) | Ā |
Physical activity | <ā0.001 | ||
Ā Regular | 29 (31.5) | 63 (68.5) | Ā |
Ā Not regular | 72 (25) | 216 (75) | Ā |
Ā No physical activity | 295 (47.4) | 328 (52.6) | Ā |
Family history of diabetes | 0.014 | ||
Ā Present | 356 (41) | 513(59) | Ā |
Ā Absent | 40 (29.9) | 94 (70.1) | Ā |
Regular visit to treating physicians | <ā0.001 | ||
Ā Yes | 342 (37.3) | 575 (62.7) | Ā |
Ā No | 54 (62.8) | 32 (37.2) | Ā |
Body mass index (kg/m2) | 0.052 | ||
Ā Normal | 32 (37.6) | 53 (62.4) | Ā |
Ā Over weight | 103 (34.1) | 199 (65.9) | Ā |
Ā Obese | 261 (42.4) | 355 (57.6) | Ā |
Duration of diabetes (year) | <ā0.001 | ||
Ā <ā5 | 29 (8.7) | 304 (91.3) | Ā |
Ā 5ā11 | 139 (39) | 217 (61) | Ā |
Ā ā„ā12 | 288 (72.6) | 86 (27.4) | Ā |
Having hypertension | <ā0.001 | ||
Ā Yes | 374 (43.5) | 486 (56.5) | Ā |
Ā No | 22 (15.4) | 121 (84.6) | Ā |
Nephropathy | <ā0.001 | ||
Ā Yes | 65 (69.1) | 29 (30.9) | Ā |
Ā No | 331 (36.4) | 578 (63.6) | Ā |
Cardiovascular disease | <ā0.001 | ||
Ā Yes | 210 (54.8) | 173 (45.2) | Ā |
Ā No | 186 (30) | 434 (70) | Ā |
Dyslipidemia | <ā0.001 | ||
Ā Yes | 381 (43) | 505 (57) | Ā |
Ā No | 15 (12.8) | 102 (87.2) | Ā |
Retinopathy | <ā0.001 | ||
Ā Yes | 132 (67.3) | 64 (32.7) | Ā |
Ā No | 264 (32.7) | 543 (67.3) | Ā |
Type of treatment | <ā0.001 | ||
Ā Insulin only | 77 (60.2) | 51 (39.8) | Ā |
Ā Oral hypoglycemia agents only | 120 (22.8) | 407 (77.2) | Ā |
Ā Oral hypoglycemia agents and insulin | 199 (57.2) | 149 (42.8) | Ā |
HbA1c (%) | <ā0.001 | ||
Ā Controlledā<ā7% | 96 (22.7) | 326 (77.3) | Ā |
Ā Uncontrolledāā„ā7% | 300 (51.6) | 281 (48.4) | Ā |